Literature DB >> 7801954

Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease.

K Suenaga1, Y Yokoyama, K Okazaki, Y Yamamoto.   

Abstract

OBJECTIVES: It is still controversial whether or not a mycobacterial infection may be a cause of Crohn's disease. Mycobacterium paratuberculosis may be very difficult to detect using routine culture techniques. To clarify this, we detected mycobacterial DNA in patients with inflammatory bowel disease.
METHODS: IS900 sequences highly specific to M. paratuberculosis and the groEL gene encoding a conserved mycobacterial antigen were studied in colonic mucosa using polymerase chain reaction (PCR). PCR products were analyzed by Southern blot hybridization.
RESULTS: IS900 sequences were detected in all (100%) of 10 patients with Crohn's disease, in 11 (61.1%) of 18 patients with ulcerative colitis, and in 14 (87.5%) of 16 control patients with noninflammatory bowel disease. All IS900 positive samples had groEL PCR products.
CONCLUSIONS: Our results, on the basis of the prevalence, do not support the hypothesis that M. paratuberculosis is involved in the pathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7801954

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; J P Van Vooren; P A Fonteyne; H De Beenhouwer; F Portaels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

3.  Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues.

Authors:  Jay L E Ellingson; John C Cheville; Dominique Brees; Janice M Miller; Norman F Cheville
Journal:  Clin Med Res       Date:  2003-07

Review 4.  Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.

Authors:  K Hultén; A Almashhrawi; F A El-Zaatari; D Y Graham
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.

Authors:  Franck Biet; Laurent Gendt; Eric Anton; Eric Ballot; Jean-Pierre Hugot; Catherine Johanet
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

6.  Colonic tuberculosis clinically misdiagnosed as anorexia nervosa, and radiologically and histopathologically as Crohn's disease.

Authors:  Tariq A Madani
Journal:  Can J Infect Dis       Date:  2002-03

Review 7.  Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients.

Authors:  Saleh A Naser; Sudesh R Sagramsingh; Abed S Naser; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis.

Authors:  Charles N Bernstein; James F Blanchard; Patricia Rawsthorne; Michael T Collins
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls.

Authors:  Charles N Bernstein; Gopi Nayar; Andre Hamel; James F Blanchard
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; P A Fonteyne; J P Van Vooren; J Deviere; F Portaels
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.